Simplicia's Atlas™ platform systematically scores global cross-cultural medical evidence—spanning traditional pharmacopoeia, ethnobotanical science, and modern pharmacology—under citation-bound provenance. The platform routes each finding to its optimal development pathway, whether that's a new chemical entity (NCE), a 505(b)(2) regulatory filing, or a clinically-formulated dietary supplement. Built for drug developers and institutions working at the frontier of natural-product discovery, Atlas™ currently catalogs 22,840 compounds and 1.2 million therapeutic patents.
Funding
Funding not disclosed
Founders
Product
Problem
Natural-product drug discovery is fragmented across traditional pharmacopoeias, ethnobotanical records, and modern pharmacological literature, making it difficult to systematically evaluate cross-cultural medical evidence. Without a unified, citation-bound framework, developers struggle to identify which traditional remedies warrant further investigation and which regulatory pathway best suits each candidate, slowing the translation of traditional medicine into validated therapeutics.
Solution
Simplicia's Atlas™ platform aggregates and scores global cross-cultural medical evidence, combining traditional pharmacopoeia, ethnobotanical science, and modern pharmacology under strict citation-bound provenance. The platform systematically evaluates each compound's evidence base and routes it to the most appropriate development path: new chemical entity (NCE) development, 505(b)(2) regulatory filing, or clinically-formulated dietary supplement. By assigning each finding to its optimal pathway, Atlas™ reduces the guesswork in natural-product research and accelerates the transition from traditional knowledge to evidence-based therapeutic candidates.
Target Audience
The primary customers are drug developers, research institutions, and natural-product discovery teams seeking a systematic, evidence-driven approach to evaluating traditional medicine and advancing candidates through regulatory pathways.
Features
- Structured scoring system that integrates traditional pharmacopoeia, ethnobotanical science, and modern pharmacology into a unified evidence framework
- Citation-bound provenance tracking that links every data point to its source for transparent, auditable research
- Intelligent routing algorithm that determines the optimal development pathway—NCE, 505(b)(2), or supplement—for each compound based on its evidence profile
- Database encompassing 22,840 compounds and 1.2 million therapeutic patents for broad cross-cultural analysis
- AI-native platform designed for drug developers and institutions specializing in natural-product discovery